You have a talent for one liner zingers, that is for sure. Maybe you should take your act to Vegas eh (LOL). Just kidding. All retail shareholders at this point have varying degrees of frustration with AMST. I respectfully disagree with your analysis though. I believe that the current team is clearing out the woodshed and correcting major problems before the eventual launch of the business into N. America. The current leadership has a powerful plan ready to exploit all five potential revenue streams and possibly create the most dynamic and flexible (and profitable) stem cell company in the industry. Histostem accounting is the log jam right now. I believe this issue will be corrected sometime in the 1st Qtr next year (just my guess). I'm holding a core position and hopefully will be trading certain blocks in the future. I am adding at these lower levels in anticipation of the plan coming together soon. Hawk is deeply rooted in their industry and has the capacity to help AMST grow their market cap exponentially. They would not continue to do business with Dwight if they did not believe he can deliver. So, you can see that we respectfully have very different views on the situation. I am adding because I am "buying management" so to speak, and you seemingly are exhausted with your frustration with management. Their goal is to be open with shareholders in the immediate future. How about you try adding some positive sentiment to your messages when delivering them to the company. Who knows what kind of rapport you can develop eh. Anyway, I'm sure there will be some negative one liners coming my way again for my sentiments. I prefer to believe in the company at this point, where others do not. Sell your shares and move on to another investment if you don't think the company can deliver.....
Market Data 
Markets 
AI
